Supersaturated Oxygen Therapy for Refractory No‐Reflow Following PCI for Non–ST‐Elevation ACS
No-reflow is high-risk complication of PCI, associated with larger infarct size, ventricular dysfunction, and mortality. We describe a 62-year-old man with a distal RCA lesion who developed refractory no-reflow despite extensive pharmacologic therapy and thrombectomy. Supersaturated oxygen therapy, used as a bail-out strategy, restored distal perfusion and may represent an emerging option for patients with severe, treatment-resistant no-reflow.
Authors
- Emmanouil S. Brilakis (ORCID: https://orcid.org/0000-0001-9416-9701)
- Pedro E P Carvalho (ORCID: https://orcid.org/0000-0002-0918-6759)
- Yader B. Sandoval (ORCID: https://orcid.org/0000-0003-4800-2972)
- Jay H. Traverse (ORCID: https://orcid.org/0000-0002-2108-0252)
Institutions
- Abbott Northwestern Hospital (US)
- Minneapolis Heart Institute Foundation (US)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2026-11-10
- DOI
- https://doi.org/10.1002/ccd.70961
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00